According to a new report published by Pristine Intelligence LLP, titled, “In Vitro Fertilization Market by Product Type, Type, Cycle, and End-User: Global Opportunity Analysis and Industry Forecast, 2024–2032,” the Global In Vitro Fertilization market size was valued at USD 759.40 million in 2023 and is projected to reach USD 1718.69 million by 2032, registering a CAGR of 9.5% from 2024 to 2032. The In Vitro Fertilization market in Global has witnessed substantial growth in recent years, driven by factors such as Delayed Pregnancy, or Difficulty in Conceiving. The IVF technique helps overcome infertility by addressing issues such as blocked fallopian tubes or low sperm count. It is used for genetic screening of embryos, enabling the selection of healthy ones to reduce the risk of genetic disorders.
This technique also allows for fertility preservation through cryopreservation, helpful for individuals undergoing treatments like chemotherapy. It also enables same-gender couples and single individuals to have biological children through gestational surrogacy. IVF has advanced reproductive research and improved assisted reproductive technologies.
The increasing demand for Fertility and Shifts in Family Planning norms is driving towards fertility options. One of the key drivers is the Delayed Onset of Pregnancy and the growing recognition of the benefits of Vitro Fertilization in reducing women’s Infertility Problems. Growing awareness and acceptance of reproductive technologies like IVF have led to increased usage. Some individuals also preserve fertility through egg or embryo freezing using cryopreservation.
The emergence of increased launches of IVF Facilities and New Technologies presents a significant opportunity for the Global In Vitro Fertilization market. Stem Cell treatment involves using undifferentiated cells to repair damaged tissue in the ovaries to improve fertility outcomes. Laser Assisted Hatching helps embryos implant in the uterus, increasing IVF success rates. Mitochondrial Replacement Therapy prevents mitochondrial diseases. Preimplantation Genetic Screening and In Vitro Maturation Techniques improve pregnancy chances. Time-lapse imaging in Embryoscopy Treatment selects viable embryos for transfer, reducing multiple pregnancies.
Global In Vitro Fertilization Market, Segmentation
The In Vitro Fertilization market is segmented based on Product Type, Type, Cycle, and End-User, and region.
Fresh Non-Donor Segment:
Fresh non-donor cycles in IVF have higher success rates as fresh eggs and sperm have better chances of successful fertilization and implantation. These cycles provide personalized treatment with a closer genetic match, increasing success likelihood.
Access to intended parents' eggs and sperm is easier than getting donor gametes, making it more manageable and accessible. Additionally, they are more cost-effective than using donor eggs or frozen embryos, making them a preferred choice for many seeking IVF treatment.
Fertility Clinics:
In the Global In Vitro Fertilization market, the Fertility clinic system represents a popular and practical solution for Infertility Problems for women. Fertility clinics offer specialized healthcare services, including IVF, staffed with skilled specialists in reproductive health. They provide a range of fertility treatments, diagnostic testing, and post-treatment monitoring.
These clinics conduct research and clinical trials to advance techniques like sperm injection and genetic testing. Collaborating with other healthcare providers, they play a major role in assisting individuals and couples with reproductive services, making them a primary choice for those seeking fertility treatments.
Region:
The Region analysis of the Global In Vitro Fertilization market highlights the dominance of Asia-Pacific where In Vitro Fertilization services are prevalent. The Asia Pacific region has a large population and fertility issues due to changing lifestyles and delayed pregnancies. The demand for In-vitro Fertilization (IVF) services is on the rise, driven by factors like increased awareness and technological advancements. IVF success rates have improved with advancements in laboratory techniques and genetic testing. Rising incomes and medical tourism in countries like China, Japan, and India are making IVF more accessible, supported by government policies and funding.
Some of The Active Market Players Are-
- Tfp Fertility (UK)
- Vitrolife Ab (Sweden)
- Irvine Scientific (USA)
- Thermo Fisher Scientific Inc. (USA)
- Merck Kgaa (Emd Serono) (Germany)
- Ferring Pharmaceuticals (Switzerland)
- Esco Micro Pte Ltd (Singapore)
- Boston Ivf (USA)
- Ivftech Aps (Denmark)
- Rocket Medical Plc (USA)
- Ivi Fertility (Spain)
- The Cooper Companies, Inc. (USA)
- Cook Group (USA)
- Vitrolife (Sweden)
- Servy Massey Fertility Institute (USA)
- Houston Fertility Center (USA) and Other Active Players.
Key Industry Developments
- In April 2024, Gameto a female-led biotechnology company with a mission to redefine women's healthcare, Announced New Data Demonstrating Clinical-Grade Manufacturing of In Vitro Maturation Solutions for Fertility Care.
- In March 2024, Alife Health a leading fertility technology company specializing in the development of AI tools for in vitro fertilization announced a groundbreaking partnership with Boston IVF, a leading fertility clinic.
Key Findings of the Study
- Global In Vitro Fertilization market growth driven by Delayed Onset of Pregnancy.
- Increase Launches of IVF Facilities and New Technologies offer a significant opportunity for longer commutes and hilly areas.
- Fresh non-donor cycles often have higher success rates when compared to other segments.
- Fertility clinics are dedicated to healthcare facilities that are equipped with specialized infrastructure, laboratories, and advanced reproductive technologies that offer fertility treatments.
